Search Results - Adam Kashishian

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo.

    Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. by Adam Kashishian, Andrius Kazlauskas, Jonathan A. Cooper

    Published 1992
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit.

    GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit. by Andrius Kazlauskas, Adam Kashishian, Jonathan A. Cooper, Mindaugas Valius

    Published 1992
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.

    Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. by Riko Nishimura, W Li, Adam Kashishian, Anna Mondino, Min Zhou, Jonathan A. Cooper, Joseph Schlessinger

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    AKAP79 Inhibits Calcineurin through a Site Distinct from the Immunophilin-binding Region

    AKAP79 Inhibits Calcineurin through a Site Distinct from the Immunophilin-binding Region by Adam Kashishian, Monique Howard, Christine Loh, W. Michael Gallatin, Merl F. Hoekstra, Yvonne Y. Lai

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma

    PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma by Sarah Meadows, Francisco Vega, Adam Kashishian, Dave Johnson, Volker Diehl, Langdon L. Miller, Anas Younes, Brian J. Lannutti

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.

    Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. by Robert J. Lechleider, Satoru Sugimoto, Anton M. Bennett, Adam Kashishian, Jonathan A. Cooper, Steven E. Shoelson, Christopher T. Walsh, Benjamin G. Neel

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    p110δ, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in Leukocytes

    p110δ, a Novel Phosphatidylinositol 3-Kinase Catalytic Subunit That Associates with p85 and Is Expressed Predominantly in Leukocytes by David Chantry, Anne B. Vojtek, Adam Kashishian, Douglas A. Holtzman, Christi L. Wood, Patrick W. Gray, Jonathan A. Cooper, Merl F. Hoekstra

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    DNA-Dependent Protein Kinase Is a Molecular Target for the Development of Noncytotoxic Radiation–Sensitizing Drugs

    DNA-Dependent Protein Kinase Is a Molecular Target for the Development of Noncytotoxic Radiation–Sensitizing Drugs by Eric T. Shinohara, Ling Geng, Jiahui Tan, Heidi Chen, Yu Shir, E. Edwards, James Halbrook, Edward A. Kesicki, Adam Kashishian, Dennis E. Hallahan

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Targeting Nonclassical Oncogenes for Therapy in T-ALL

    Targeting Nonclassical Oncogenes for Therapy in T-ALL by Prem S. Subramaniam, Dosh Whye, Evgeni Efimenko, Jianchung Chen, Valeria Tosello, Kim De Keersmaecker, Adam Kashishian, Mary Ann Thompson, Mireia Castillo‐Martin, Carlos Cordón-Cardo, Utpal P. Davé, Adolfo A. Ferrando, Brian J. Lannutti, Thomas G. Diacovo

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

    CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability by Brian J. Lannutti, Sarah Meadows, Sarah E.M. Herman, Adam Kashishian, Bart Steiner, Amy J. Johnson, John C. Byrd, Jeffrey W. Tyner, Marc Loriaux, Mike Deininger, Brian J. Druker, Kamal D. Puri, Roger G. Ulrich, Neill A. Giese

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: